AJMALINE IN CARDIAC ARRHYTHMIAS Ineffectivity or Indifference?
DOI:
https://doi.org/10.47144/phj.v14i2.474Keywords:
AJMALINE IN CARDIAC ARRHYTHMIAS Ineffectivity or Indifference?Abstract
Ajmaline, an indolin base, was first isolated from the Indian plant rauwolfia serpentina by Dr. Salimuzzaman Saddiqui (1) and named after Hakim Ajmal Khan, a pioneer of Tib in India. It is a member of a. second group of rauwolfic derivatives whick have no sedative, hypnotic, or hypotensive effects. Arora et al. (1956) in the subcontinent and Kleinsorge (1965) in the Europe confirmed its anti.-arrhythmic efficacy and this has been substantiated” (Ilyas 1970, 1981, Klein et al 1980).
Toxic effects of ajmaline include hypotens ion, decreased cardiac output and atrioventric ular block. It is contraindicated in atrial flutter and severe conduction disorders. Side effects were reported in 3/66 cases (3%: Forster et al. 1966). Rarely ajmaline has been used suicidally by over_dosage (Hager et al. 1968).
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/
